MYCN oncoprotein targets and their therapeutic potential

被引：90

作者：

Bell, Emma ^{[1
]}

Chen, Lindi ^{[1
]}

Liu, Tao ^{[2
]}

Marshall, Glenn M. ^{[2
]}

Lunec, John ^{[1
]}

Tweddle, Deborah A. ^{[1
]}

机构：

[1] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Childrens Canc Inst Australia, Sydney, NSW, Australia

来源：

CANCER LETTERS | 2010年 / 293卷 / 02期

基金：

英国医学研究理事会;

关键词：

MYCN; Microarrays; Neuroblastoma; Target genes; HUMAN NEUROBLASTOMA-CELLS; DIRECT TRANSCRIPTIONAL TARGET; DEACETYLASE INHIBITOR BL1521; PEPTIDE NUCLEIC-ACID; ARF TUMOR-SUPPRESSOR; MRP GENE-EXPRESSION; N-MYC; C-MYC; ORNITHINE-DECARBOXYLASE; CENTROSOME AMPLIFICATION;

D O I：

10.1016/j.canlet.2010.01.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The MYCN oncogene encodes a transcription factor which is amplified in up to 40% of high risk neuroblastomas. MYCN amplification is a well-established poor prognostic marker in neuroblastoma, however the role of MYCN expression and the mechanisms by which it acts to promote an aggressive phenotype remain largely unknown. This review discusses the current evidence identifying the direct and indirect downstream transcriptional targets of MYCN from recent studies, with particular reference to how MYCN affects the cell cycle, DNA damage response, differentiation and apoptosis in neuroblastoma. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：144 / 157

页数：14

共 154 条

[61] ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Hogarty, Michael D.
Norris, Murray D.
Davis, Kimberly
Liu, Xueyuan
Evageliou, Nicholas F.
Hayes, Candace S.
Pawel, Bruce
Guo, Rong
Zhao, Huaqing
Sekyere, Eric
Keating, Joanna
Thomas, Wayne
Cheng, Ngan Ching
Murray, Jayne
Smith, Janice
Sutton, Rosemary
Venn, Nicola
London, Wendy B.
Buxton, Allen
Gilmour, Susan K.
Marshall, Glenn M.
Haber, Michelle
[J]. CANCER RESEARCH, 2008, 68 (23) : 9735 - 9745
[62] N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1(NLRR1) gene in neuroblastoma
Hossain, M. S.
Ozaki, T.
Wang, H.
Nakagawa, A.
Takenobu, H.
Ohira, M.
Kamijo, T.
Nakagawara, A.
[J]. ONCOGENE, 2008, 27 (46) : 6075 - 6082
[63] Dickkopf-3/REIC functions as a suppressor gene of tumor growth
Hsieh, SY
Hsieh, PS
Chiu, CT
Chen, WY
[J]. ONCOGENE, 2004, 23 (57) : 9183 - 9189
[64] Expression profiling reveals off-target gene regulation by RNAi
Jackson, AL
Bartz, SR
Schelter, J
Kobayashi, SV
Burchard, J
Mao, M
Li, B
Cavet, G
Linsley, PS
[J]. NATURE BIOTECHNOLOGY, 2003, 21 (06) : 635 - 637
[65] An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant
Ji, P
Jiang, H
Rekhtman, K
Bloom, J
Ichetovkin, M
Pagano, M
Zhu, L
[J]. MOLECULAR CELL, 2004, 16 (01) : 47 - 58
[66] Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
Johnsen, J. I.
Segerstrom, L.
Orrego, A.
Elfman, L.
Henriksson, M.
Kagedal, B.
Eksborg, S.
Sveinbjornsson, B.
Kogner, P.
[J]. ONCOGENE, 2008, 27 (20) : 2910 - 2922
[67] The concept of synthetic lethality in the context of anticancer therapy
Kaelin, WG
[J]. NATURE REVIEWS CANCER, 2005, 5 (09) : 689 - 698
[68] N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma
Kang, J.
Rychahou, P. G.
Ishola, T. A.
Mourot, J. M.
Evers, B. M.
Chung, D. H.
[J]. ONCOGENE, 2008, 27 (28) : 3999 - 4007
[69] MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells
Kang, Jung-Hee
Rychahou, Piotr G.
Ishola, Titilope A.
Qiao, Jingbo
Evers, B. Mark
Chung, Dal H.
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (01) : 192 - 197
[70] Regulation of prostate cell growth and morphogenesis by Dickkopf-3
Kawano, Y.
Kitaoka, M.
Hamada, Y.
Walker, M. M.
Waxman, J.
Kypta, R. M.
[J]. ONCOGENE, 2006, 25 (49) : 6528 - 6537

← 2 3 4 5 6 7 8 9 10 11 →